Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. FBTAX: which is better?

Bottom line

BBH vs FBTAX: the short answer

BBH (VanEck Biotech ETF) and FBTAX (Fidelity Advisor Biotechnology Fund) are quite different portfolios: only about 35% of their top holdings (by weight) are shared.

But FBTAX is far broader, holding 129 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 0.94% — a difference of $59 a year per $10,000 invested.

Over five years, FBTAX returned +6.4% a year vs +2.7% for BBH (reporting dates differ).

Updated Nov 19, 2026

BBH vs FBTAX side by side

BBHFBTAX
TypeETFMutual fund
Fund familyVanEckFidelity
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.94%
Annual cost per $10k$35$94
10-yr cost on $10k (prospectus)$443$1,663
Max front loadNone—
12b-1 fee—0.25%
1-yr return+21.2%+31.5%
5-yr return (annualized)+2.7%+6.4%
10-yr return (annualized)+4.5%+7.7%
Best quarter+27.6%+30.3%
Worst quarter−18.2%−27.8%
Net assets (fund)$395.6M$2.2B
Number of holdings25129
Portfolio turnover19%54%
Returns as ofDec 31, 2025Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHFBTAXDifference
2025+21.2%+39.6%−18.4%
2024−4.4%+5.3%−9.7%
2023+3.9%+10.7%−6.8%
2022−15.1%−8.0%−7.2%
2021+11.8%−3.6%+15.3%
2020+22.1%+32.2%−10.1%
2019+25.8%+25.7%+0.1%
2018−10.2%−3.8%−6.4%
2017+16.6%+25.8%−9.2%
2016−15.0%−23.6%+8.5%

Source: Fund prospectus bar charts

Holdings overlap

10 of BBH's top 25 holdings also appear in FBTAX's top 25.

Shared top holdings
HoldingBBHFBTAX
Amgen Inc15.25%2.37%
Gilead Sciences Inc12.79%5.70%
Vertex Pharmaceuticals Inc9.10%1.39%
Revolution Medicines Inc5.27%3.00%
Argenx SE4.97%3.00%
Natera Inc4.92%1.43%
Alnylam Pharmaceuticals Inc3.83%3.62%
Biogen Inc3.63%2.71%
Moderna Inc3.36%1.60%
Insmed Inc2.67%3.05%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

FBTAX top 10

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%

FAQ

What is the difference between BBH and FBTAX?
BBH (VanEck Biotech ETF) and FBTAX (Fidelity Advisor Biotechnology Fund) are quite different portfolios: only about 35% of their top holdings (by weight) are shared. But FBTAX is far broader, holding 129 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or FBTAX?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and FBTAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.